Trial Profile
The prophylactic effect of continuously infused landiolol started just before the end of surgery against tachycardia during tracheal extubation
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2013
Price :
$35
*
At a glance
- Drugs Landiolol (Primary)
- Indications Tachycardia
- Focus Therapeutic Use
- 20 Mar 2013 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 07 Jun 2011 New trial record